Caladrius Biosciences
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.64-53.10-0.13-0.06-0.55-1.94-2.13-1.33-2.71-0.47-1.05-1.05
Price/Sales ratio
6.18142.940.420.230.52N/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
2.6733.520.130.223.790.620.911.240.670.140.310.62
Price/Cash Flow ratio
-6.39-77.36-0.16-0.13-0.78-1.50-1.72-1.37-2.50-0.58-1.26-1.26
Price/Free Cash Flow ratio
-6.15-70.37-0.15-0.12-0.69-1.49-1.71-1.37-2.49-0.58-1.25-1.25
Price/Earnings Growth ratio
-0.06-2.030.010.040.000.030.29-0.100.03-0.000.000.03
Dividend Yield
0.37%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
16.61%11.73%12.60%10.35%11.75%N/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
-212.04%-258.51%-302.25%-426.90%-86.89%N/AN/AN/AN/AN/AN/A-86.89%
Pretax Profit Margin
-253.15%-263.86%-309.77%-436.92%-94.01%N/AN/AN/AN/AN/AN/A-94.01%
Net Profit Margin
-375.22%-269.18%-309.19%-360.24%-94.40%N/AN/AN/AN/AN/AN/A-94.40%
Effective Tax Rate
0.48%-2.01%0.18%17.54%-0.41%41.61%-0.03%-0.04%57.18%5.20%9.16%-0.41%
Return on Assets
-98.82%-43.96%-43.92%-141.61%-64.26%-25.51%-36.27%-71.30%-22.61%-28.31%-28.61%-64.26%
Return On Equity
-162.06%-63.13%-94.79%-341.62%-682.02%-32.01%-42.86%-93.01%-25.05%-29.85%-27.18%-682.02%
Return on Capital Employed
-68.34%-47.39%-49.27%-265.26%-94.83%21.88%-41.48%-91.42%-58.53%-31.32%-32.90%-94.83%
Liquidity Ratios
Current Ratio
1.675.182.231.391.266.567.844.3410.07N/A22.321.26
Quick Ratio
1.484.892.231.391.266.567.844.3410.0720.9921.741.26
Cash ratio
1.384.701.180.960.753.131.832.344.7020.999.930.75
Days of Sales Outstanding
26.8346.3063.3041.6529.91N/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
33.9935.80N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Cycle
60.8382.1163.3041.6529.91N/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
78.0594.57131.7974.3651.190.0116.3727.0619.4424.29N/A0.01
Cash Conversion Cycle
-17.21-12.46-68.48-32.71-21.27N/AN/AN/AN/AN/AN/A-21.27
Debt Ratios
Debt Ratio
0.390.300.130.290.130.00N/A0.010.01N/A0.040.04
Debt Equity Ratio
0.650.440.280.701.390.00N/A0.010.01N/A0.040.04
Long-term Debt to Capitalization
0.000.050.200.320.36N/AN/AN/AN/AN/A0.00N/A
Total Debt to Capitalization
0.100.060.220.410.580.00N/A0.010.01N/A0.000.00
Interest Coverage Ratio
-19.26-130.79-76.40-24.23-16.86-73.04-3.39KN/AN/AN/AN/A-16.86
Cash Flow to Debt Ratio
-3.63-6.53-2.81-2.34-3.48-131.14N/A-53.33-23.84N/A-36.26-36.26
Company Equity Multiplier
1.631.432.152.4110.611.251.181.301.101.051.041.25
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.96-1.84-2.61-1.74-0.67N/AN/AN/AN/AN/AN/A-0.67
Free Cash Flow / Operating Cash Flow Ratio
1.031.091.071.081.121.001.0011.001.001.011.01
Cash Flow Coverage Ratio
-3.63-6.53-2.81-2.34-3.48-131.14N/A-53.33-23.84N/A-36.26-36.26
Short Term Coverage Ratio
-3.80-45.60-24.34-7.31-5.95-131.14N/A-53.33-23.84N/A-114.30-131.14
Dividend Payout Ratio
-0.60%N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A